Epilepsy is among the most common neurological disorders, affecting individuals across all age groups [1]. While the prevalence is rising among older adults due to the aging of the global population, its incidence remains highest among young people [2]. Thus, the disease affects persons in their productive years. Despite the availability of over 30 antiseizure medications (ASMs) and nonpharmacological treatments, approximately one-third of patients fail to achieve seizure remission, posing significant clinical and social challenges [3,4].
4
MAY
MAY
0